Skip to main content

Cerevel Therapeutics Holdings, Inc.

CEREDelisted Aug 1, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001805387

Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.

Q4 2025 vs. Q3 2025

How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of CERE: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders01+1
Shares01.00K+1.00K
Value$0$1.16K+$1.16K

New holders (1)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CERE in Q4 2025
InstitutionSharesValue% of portfolio
Meteora Capital, LLC1,000$1.16K0.00%

Sold out (0)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

None.